Lupus News and Research

Latest Lupus News and Research

Researchers define pathway that helps us make antibodies

Our bodies are continuously concocting specific antibodies to thwart invaders like a virus or even pollen, and scientists have new information about how the essential production gets fired up and keeps up.

13 Mar 2019

CAR-T cell therapy could be on the horizon for patients with lupus

Researchers have developed a novel CAR-T cell therapy that can reduce B cell numbers known to cause the inflammatory responses in lupus.

7 Mar 2019

New approach to tackling chronic inflammatory diseases

An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualized treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.

1 Mar 2019

Suppressing cancer-causing protein could correct increased fibrosis in scleroderma patients

A protein known to play a role in cancer may also be increasing fibrosis in scleroderma patients.

27 Feb 2019

Immunologists uncover the immune system's unknown messenger

A novel messenger which alarms nearby cells when the immune system recognizes infections has been uncovered by immunologists from Aarhus University, Denmark. This knowledge will help fighting infections and autoimmune diseases.

26 Feb 2019

More states say doctors must offer overdose reversal drug along with opioids

In a growing number of states, patients who get opioids for serious pain may leave their doctors' offices with a second prescription — for naloxone, a drug that can save their lives if they overdose on the powerful painkillers.

21 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

Advanced scan shows brain inflammation related to post-treatment Lyme disease syndrome

More than 1 in 10 people successfully treated with antibiotics for Lyme disease go on to develop chronic, sometimes debilitating, and poorly understood symptoms of fatigue and brain fog that may last for years after their initial infection has cleared up.

6 Feb 2019

Psoriasis treatment associated with reduction in coronary artery disease

Researchers have found that treating psoriasis, a chronic inflammatory skin disease, with biologic drugs that target immune system activity can reduce the early plaque buildup that clogs arteries, restricts blood flow, and leads to heart attacks and stroke.

5 Feb 2019

New system for early detection of lupus developed

Autoimmune diseases, such as systemic lupus erythematosus or rheumatoid arthritis, are difficult to diagnose, specially in early stages. Specifically, in the case of lupus, specific antibodies aimed at antigens located in the nucleus of cells appear, including the anti-Ro/SSA.

1 Feb 2019

OU researcher and collaborators are developing new strategies for early intervention of Lupus

A University of Oklahoma researcher, Si Wu, and collaborators from the Oklahoma Medical Research Foundation and Indiana University, are developing new strategies leading to diagnosis and early intervention of Lupus, an autoimmune disease that may affect up to 1.5 million Americans.

1 Feb 2019

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Checkpoint inhibitor therapy is a form of cancer treatment immunotherapy currently under research. The therapy targets immune checkpoints, key regulators of the immune system that stimulate or inhibit its actions, which tumors can use to protect themselves from attacks by the immune system.

18 Jan 2019

Lupus Research Alliance announces research awards to accelerate development of new therapies

Can "borrowed" drugs for treating other diseases protect the skin in patients with lupus? Can researchers coax the body to weed out harmful immune cells that drive tissue destruction in lupus? Those are just two of the innovative approaches for lupus therapies recognized by the Lupus Research Alliance with the latest round of its Target Identification in Lupus grants.

11 Jan 2019

New method modifies blood stem cells to reverse genetic mutation that causes IPEX

UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX.

11 Jan 2019

Researchers reveal how dietary intervention can help prevent autoimmune disease in mice

Could a change in diet be beneficial to people with autoimmune diseases such as lupus? A Yale-led team of researchers have revealed how a dietary intervention can help prevent the development of this autoimmune disease in susceptible mice.

21 Dec 2018

Lupus Research Alliance announces 2018 recipients of the Distinguished Innovator Award

The Lupus Research Alliance is proud to announce the 2018 recipients of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Nir Hacohen, PhD and Vijay Kuchroo, DVM, PhD. Dr. Hacohen is seeking better ways to treat lupus kidney disease, the major cause of illness and death among patients with lupus.

21 Dec 2018

Scripps Research finds molecular cause of a group of rare autoimmune disorders

A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's own healthy cells.

20 Dec 2018

Allen Institute for Immunology: A new division focused on human immune system

The Allen Institute today announced the launch of the Allen Institute for Immunology, a new division of the Institute that is dedicated to studying the human immune system.

13 Dec 2018

Discovery could be used to prevent viral infection and autoimmunity

Researchers have discovered that chemical changes to mRNA regulate the production of interferon beta, and hope to exploit this in new treatments.

27 Nov 2018

Location matters for inflammation clearance

Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, problems arise when it persists, potentially harming surrounding tissues.

20 Nov 2018

Lupus News and Research

Latest Lupus News and Research

Researchers define pathway that helps us make antibodies

CAR-T cell therapy could be on the horizon for patients with lupus

New approach to tackling chronic inflammatory diseases

Suppressing cancer-causing protein could correct increased fibrosis in scleroderma patients

Immunologists uncover the immune system's unknown messenger

More states say doctors must offer overdose reversal drug along with opioids

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

Advanced scan shows brain inflammation related to post-treatment Lyme disease syndrome

Psoriasis treatment associated with reduction in coronary artery disease

New system for early detection of lupus developed

OU researcher and collaborators are developing new strategies for early intervention of Lupus

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Lupus Research Alliance announces research awards to accelerate development of new therapies

New method modifies blood stem cells to reverse genetic mutation that causes IPEX

Researchers reveal how dietary intervention can help prevent autoimmune disease in mice

Lupus Research Alliance announces 2018 recipients of the Distinguished Innovator Award

Scripps Research finds molecular cause of a group of rare autoimmune disorders

Allen Institute for Immunology: A new division focused on human immune system

Discovery could be used to prevent viral infection and autoimmunity

Location matters for inflammation clearance

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lupus News and Research

Latest Lupus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in